Metraipolis › archive › dc_3cf4c2ee06b5
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma — Europe PMC PMID:34166362
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/34166362
- DOI
- 10.1371/journal.pgen.1009589
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-03T23:38:04.575Z
- SHA-256 of the archived text
b86cdda0cbf389d96af81c0082d68fc4900221f2a280955367dad59f4e2e3501- Stable URL of this page
https://metraipolis.com/documento/dc_3cf4c2ee06b5
How to cite
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma — Europe PMC PMID:34166362 — Europe PMC (en), https://europepmc.org/article/MED/34166362 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_3cf4c2ee06b5 (Metraipolis archive dc_3cf4c2ee06b5, sha256 b86cdda0cbf389d96af81c0082d68fc4900221f2a280955367dad59f4e2e3501)
BibTeX
@misc{dc3cf4c2ee06b5,
title = {Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma — Europe PMC PMID:34166362},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/34166362},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_3cf4c2ee06b5; sha256 b86cdda0cbf389d96af81c0082d68fc4900221f2a280955367dad59f4e2e3501},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34166362. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Cancer testis antigens (CTAs) are an extensive gene family with a unique expression pattern restricted to germ cells, but aberrantly reactivated in cancer tissues. Studies indicate that the expression (or re-expression) of CTAs within the MAGE-A family is common in hepatocellular carcinoma (HCC). However, no systematic characterization has yet been reported. The aim of this study is to perform a comprehensive profile of CTA de-regulation in HCC and experimentally evaluate the role of MAGEA3 as a driver of HCC progression. The transcriptomic analysis of 44 multi-regionally sampled HCCs from 12 patients identified high intra-tumor heterogeneity of CTAs. In addition, a subset of CTAs was significantly overexpressed in histologically poorly differentiated regions. Further analysis of CTAs in larger patient cohorts revealed high CTA expression related to worse overall survival and several other markers of poor prognosis. Functional analysis of MAGEA3 was performed in human HCC cell lines by gene silencing and in a genetic mouse model by overexpression of MAGEA3 in the liver. Knockdown of MAGEA3 decreased cell proliferation, colony formation and increased apoptosis. MAGEA3 overexpression was associated with more aggressive tumors in vivo. In conclusion MAGEA3 enhances tumor progression and should be considered as a novel therapeutic target in HCC. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS genetics, 2021 (prima pubblicazione 2021-06-24). Identificativi: PMID 34166362 · PMCID PMC8224860 · DOI 10.1371/journal.pgen.1009589. Descrittori MeSH principali: Transcriptome. Pagina: https://europepmc.org/article/MED/34166362 — https://doi.org/10.1371/journal.pgen.1009589. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-03T23:20:24.784Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.